SG11202108766RA - Live attenuated influenza vaccine composition and process for preparation thereof - Google Patents
Live attenuated influenza vaccine composition and process for preparation thereofInfo
- Publication number
- SG11202108766RA SG11202108766RA SG11202108766RA SG11202108766RA SG11202108766RA SG 11202108766R A SG11202108766R A SG 11202108766RA SG 11202108766R A SG11202108766R A SG 11202108766RA SG 11202108766R A SG11202108766R A SG 11202108766RA SG 11202108766R A SG11202108766R A SG 11202108766RA
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- vaccine composition
- live attenuated
- influenza vaccine
- attenuated influenza
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921006071 | 2019-02-15 | ||
| PCT/IN2020/050121 WO2020165912A1 (en) | 2019-02-15 | 2020-02-07 | Live attenuated influenza vaccine composition and process for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202108766RA true SG11202108766RA (en) | 2021-09-29 |
Family
ID=69740470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202108766RA SG11202108766RA (en) | 2019-02-15 | 2020-02-07 | Live attenuated influenza vaccine composition and process for preparation thereof |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20220211837A1 (en) |
| EP (1) | EP3924052A1 (en) |
| JP (1) | JP2022520443A (en) |
| KR (1) | KR20210129073A (en) |
| CN (1) | CN113646047A (en) |
| AR (1) | AR119691A1 (en) |
| AU (1) | AU2020222113A1 (en) |
| BR (1) | BR112021016059A2 (en) |
| CA (1) | CA3130036A1 (en) |
| CL (1) | CL2021002111A1 (en) |
| CO (1) | CO2021010751A2 (en) |
| IL (1) | IL285526A (en) |
| JO (1) | JOP20200037A1 (en) |
| MA (1) | MA54942A (en) |
| MX (1) | MX2021009837A (en) |
| PE (1) | PE20212322A1 (en) |
| SG (1) | SG11202108766RA (en) |
| TW (1) | TW202045205A (en) |
| UY (1) | UY38587A (en) |
| WO (1) | WO2020165912A1 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0202846A3 (en) * | 1999-09-24 | 2003-12-29 | Smithkline Beecham Biolog | Intranasal influenza virus vaccine |
| CA2517181C (en) * | 2003-02-25 | 2013-07-16 | Medimmune Vaccines, Inc. | Methods of producing influenza vaccine compositions |
| ES2633471T3 (en) * | 2004-10-06 | 2017-09-21 | Medimmune, Llc | Cold-stable flu vaccine compositions |
| RU2015103990A (en) * | 2008-09-24 | 2015-10-27 | Медиммун, Ллк | METHODS OF CULTIVATION OF CELLS, REPRODUCTION AND CLEANING OF VIRUSES |
| CA2993242C (en) * | 2010-04-15 | 2020-12-15 | Shin Nippon Biomedical Laboratories, Ltd. | Methods and compositions for intranasal delivery |
| TWI670085B (en) * | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | Swine virus vaccines that are liquid stable |
| WO2017047089A1 (en) * | 2015-09-16 | 2017-03-23 | Shin Nippon Biomedical Laboratories, Ltd. | Vaccine compositions |
| CA3069444A1 (en) * | 2017-07-11 | 2019-01-17 | Universal Stabilization Technologies, Inc. | Method for preserving biopharmaceuticals |
-
2020
- 2020-02-07 SG SG11202108766RA patent/SG11202108766RA/en unknown
- 2020-02-07 CN CN202080024926.8A patent/CN113646047A/en active Pending
- 2020-02-07 KR KR1020217027060A patent/KR20210129073A/en active Search and Examination
- 2020-02-07 WO PCT/IN2020/050121 patent/WO2020165912A1/en active Application Filing
- 2020-02-07 EP EP20708683.6A patent/EP3924052A1/en active Pending
- 2020-02-07 MA MA054942A patent/MA54942A/en unknown
- 2020-02-07 PE PE2021001342A patent/PE20212322A1/en unknown
- 2020-02-07 US US17/429,965 patent/US20220211837A1/en active Pending
- 2020-02-07 JP JP2021547436A patent/JP2022520443A/en active Pending
- 2020-02-07 MX MX2021009837A patent/MX2021009837A/en unknown
- 2020-02-07 AU AU2020222113A patent/AU2020222113A1/en active Pending
- 2020-02-07 CA CA3130036A patent/CA3130036A1/en active Pending
- 2020-02-07 BR BR112021016059-0A patent/BR112021016059A2/en unknown
- 2020-02-14 UY UY0001038587A patent/UY38587A/en unknown
- 2020-02-14 AR ARP200100405A patent/AR119691A1/en unknown
- 2020-02-14 TW TW109104708A patent/TW202045205A/en unknown
- 2020-02-16 JO JOP/2020/0037A patent/JOP20200037A1/en unknown
-
2021
- 2021-08-11 CL CL2021002111A patent/CL2021002111A1/en unknown
- 2021-08-11 IL IL285526A patent/IL285526A/en unknown
- 2021-08-13 CO CONC2021/0010751A patent/CO2021010751A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA54942A (en) | 2021-12-22 |
| BR112021016059A2 (en) | 2021-10-13 |
| KR20210129073A (en) | 2021-10-27 |
| AR119691A1 (en) | 2022-01-05 |
| PE20212322A1 (en) | 2021-12-14 |
| CA3130036A1 (en) | 2020-08-20 |
| JOP20200037A1 (en) | 2020-08-15 |
| US20220211837A1 (en) | 2022-07-07 |
| CO2021010751A2 (en) | 2021-09-09 |
| EP3924052A1 (en) | 2021-12-22 |
| CN113646047A (en) | 2021-11-12 |
| CL2021002111A1 (en) | 2022-01-28 |
| TW202045205A (en) | 2020-12-16 |
| MX2021009837A (en) | 2021-09-10 |
| IL285526A (en) | 2021-09-30 |
| AU2020222113A1 (en) | 2021-10-07 |
| UY38587A (en) | 2020-09-30 |
| JP2022520443A (en) | 2022-03-30 |
| WO2020165912A1 (en) | 2020-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201814362D0 (en) | Composition and process for preparing vaccine | |
| ZA202002852B (en) | Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof | |
| SG11202010821TA (en) | Vaccine composition | |
| ZA201904505B (en) | Universal influenza vaccine compositions | |
| SG11202100706UA (en) | Composition containing influenza vaccine | |
| HK1259146A1 (en) | Methods and compositions for influenza vaccination | |
| EP3302543A4 (en) | Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases | |
| HK1244506A1 (en) | Live attenuated vaccines for influenza viruses | |
| EP3484511A4 (en) | Vaccine compositions for treatment of zika virus | |
| GB201801566D0 (en) | Methods and compositions for nanormulsion vaccine formulations | |
| IL274897A (en) | Formulations of dengue virus vaccine compositions | |
| ZA202103154B (en) | Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same | |
| EP3305328A4 (en) | Non-gelatin vaccine protectant composition and live attenuated influenza vaccine | |
| SG11201911930SA (en) | Methods and compositions for substance use disorder vaccine formulations and uses thereof | |
| EP3445398A4 (en) | Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery | |
| SG11202009147UA (en) | Vaccine compositions | |
| EP3228323A4 (en) | Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same | |
| EP3423051A4 (en) | Compositions and methods for treatment of influenza virus | |
| IL285526A (en) | Live attenuated influenza vaccine composition and process for preparation thereof | |
| EP3615005A4 (en) | Compositions and methods for vaccine delivery | |
| HK1245097A1 (en) | Pharmaceutical composition for treatment of menopausal syndrome and preparation method thereof | |
| EP3880805A4 (en) | Live attenuated influenza b virus compositions methods of making and using thereof | |
| GB202013262D0 (en) | Vaccine Composition | |
| IL282245A (en) | Vaccine polypeptide compositions and methods | |
| EP3319629A4 (en) | Live attenuated oral vaccine against shigellosis and typhoid fever |